Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy (Q44737495)

5 December 2017

Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy (English)

1 reference

5 December 2017

Stabile LP

1

1 reference

5 December 2017

Lyker JS

series ordinal

2

1 reference

5 December 2017

Huang L

series ordinal

3

1 reference

5 December 2017

Siegfried JM

series ordinal

4

1 reference

5 December 2017

1 February 2004

1 reference

5 December 2017

1 reference

5 December 2017

11

1 reference

5 December 2017

3

1 reference

5 December 2017

325-335

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302169

5 December 2017

0 references

cites work

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Human lung cancer cell line producing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Activating mutations for the met tyrosine kinase receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Expression of c-met is a strong independent prognostic factor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Overexpression of the Met/HGF receptor in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

c-met proto-oncogene expression in benign and malignant human prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Stable transfection of human malignant melanoma cells with basic fibroblast growth factor antisense cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

A novel cationic liposome reagent for efficient transfection of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Essential role of Gab1 for signaling by the c-Met receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

K252a inhibits the oncogenic properties of Met, the HGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302169

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302169

1 reference

Dimensions Publication ID

5 December 2017

0 references

1 reference